Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-11-06 1:51 pm Sale | 13G | Alvotech ALVO | YA II PN Ltd. | 0 0.000% | -27,042,090 (Position Closed) | View |
| 2024-07-03 5:31 pm Unchanged | 13D | Alvotech ALVO | Aztiq Pharma Partners S.a r.l. | 101,147,803 33.500% | 0 (Unchanged) | View |
| 2024-02-14 12:14 pm Sale | 13G | Alvotech ALVO | Oaktree Acquisition Holdings II L.P. | 10,641,478 3.930% | -4,227,434 (-28.43%) | View |
| 2023-02-14 5:13 pm Purchase | 13G | Alvotech ALVO | Oaktree Acquisition Holdings II L.P. | 14,868,912 5.870% | 14,868,912 (New Position) | View |
| 2022-11-18 4:05 pm Purchase | 13D | Alvotech ALVO | Celtic Holdings SCA | 90,005,334 36.200% | 1,064,715 (+1.20%) | View |
| 2022-07-18 4:03 pm Purchase | 13D | Alvotech ALVO | Aztiq Pharma Partners S.a r.l. | 101,147,803 40.680% | 2,500,000 (+2.53%) | View |
| 2022-07-15 4:15 pm Purchase | 13D | Alvotech ALVO | Celtic Holdings SCA | 88,940,619 36.500% | 2,500,000 (+2.89%) | View |
| 2022-07-01 6:19 pm Purchase | 13D | Alvotech ALVO | Aztiq Pharma Partners S.a r.l. | 98,647,803 40.490% | 98,647,803 (New Position) | View |
| 2022-06-27 4:05 pm Purchase | 13D | Alvotech ALVO | Celtic Holdings SCA | 86,440,619 35.500% | 86,440,619 (New Position) | View |
| 2022-06-22 4:46 pm Purchase | 13G | Alvotech ALVO | YA II PN Ltd. | 27,042,090 9.990% | 27,042,090 (New Position) | View |